Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Gastrointestinal Stromal Tumors × Imatinib Mesylate × Clear all

Phase

Phase 2 26 Phase 3 17 Phase 1 9 Phase 1/2 4 Phase 4 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Head and Neck Neoplasms 1 Gastrointestinal Stromal Tumors 1

Interventions

entacapone 1 Imatinib Mesylate 1 68Ga-NOTA-RM26 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04006769 2023-10-18

Entacapone Combination With Imatinib for Treatment of GIST

Xiangya Hospital of Central South University

Phase EARLY_PHASE1 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡